Follow the ADURO BIOTECH, INC. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 11 January 2016 (Levée d'options). Among the most active insiders: ISAACS STEPHEN T. Every trade is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ADURO BIOTECH, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ADURO BIOTECH, INC. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para el cáncer. La empresa cotiza en NASDAQ bajo el símbolo ADRO.